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Abstract
Background:  Rapid progress in high-throughput biotechnologies (e.g. microarrays) and
exponential accumulation of gene functional knowledge make it promising for systematic
understanding of complex human diseases at functional modules level. Based on Gene Ontology, a
large number of automatic tools have been developed for the functional analysis and biological
interpretation of the high-throughput microarray data.
Results: Different from the existing tools such as Onto-Express and FatiGO, we develop a tool
named GO-2D for identifying 2-dimensional functional modules based on combined GO
categories. For example, it refines biological process categories by sorting their genes into different
cellular component categories, and then extracts those combined categories enriched with the
interesting genes (e.g., the differentially expressed genes) for identifying the cellular-localized
functional modules. Applications of GO-2D to the analyses of two human cancer datasets show
that very specific disease-relevant processes can be identified by using cellular location information.
Conclusion: For studying complex human diseases, GO-2D can extract functionally compact and
detailed modules such as the cellular-localized ones, characterizing disease-relevant modules in
terms of both biological processes and cellular locations. The application results clearly
demonstrate that 2-dimensional approach complementary to current 1-dimensional approach is
powerful for finding modules highly relevant to diseases.
Background
It is widely accepted that functionally related genes tend
to express and perform their highly concerted cellular
functions in some isolated and interactive modular fash-
ions [1,2]. Global gene expression data have provided an
opportunity for understanding the transcriptional modu-
larity characterizing complex diseases [3-6]. For example,
Mootha et al. [6] showed that the coordinate disease-asso-
ciated changes of a set of functionally related genes could
be identified even when the expression of individual
genes changes modestly. Segal et al. [3] defined 'modules'
as gene sets that are conditionally activated or repressed
across a wide variety of cancer types, and identified some
modules deregulated in cancer. Our recent study demon-
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strated that based on functional modules, i.e., GO catego-
ries enriched with differentially expressed genes (DEGs),
cancer types can be precisely and robustly classified by
supervised classification analysis [5] or discovered by clus-
tering analysis [7].
For high-throughput microarray data analysis, translating
lists of interesting genes (e.g., DEGs) into functional mod-
ules for understanding the biological phenomena has
become an important routine task. Based on Gene Ontol-
ogy, a large number of tools such as Onto-Express [8],
FatiGO [9], GoMiner [10] and GOstat [11] have been
developed for this purpose. However, most existing
approaches interpret the interesting genes using categories
from three ontologies "biological process" (BP), "molecu-
lar function" (MF) and "cellular component" (CC) sepa-
rately, which may be inefficient for mapping some specific
modular activities in cells. For example, a GO BP category
usually encompasses the genes involved in distinct proc-
esses occurring in different cellular compartments [12],
and the genes even within a same process may show a
clear expression distinction with respect to their cellular
localizations [13]. Therefore, in this paper, by combining
categories from BP, CC, and MF, we propose GO-2D as a
tool for finding 2-dimensional functional modules (e.g.,
the cellular-localized modules) for studying complex
human diseases.
We use two cancer datasets for numerical analysis, and the
results show that with the same FDR (false discovery rate)
criteria, many specific processes relevant to diseases can-
not be found until additionally cellular location informa-
tion is used. The results clearly demonstrate the
insufficiency of current 1-dimensional approaches and
highlight the importance of using 2-dimensional modules
for disease analysis.
Implementation
GO-2D has been implemented in JAVA and intercon-
nected to a relational database system by using MS-Access
2000 for Windows version and SQLite for Linux version.
Database
In GO-2D, associations of gene IDs from different organ-
isms (including Homo sapiens,  Drosophila melanogaster,
Caenorhabditis elegans, and Saccharomyces cerevisiae) to GO
terms are based on the databases Gene, SGD, FlyBase, and
WormBase. Tables relating GO terms with gene IDs can be
found in the NCBI web page [14] and GO Consortium
web page [15]. The Unigene build #190 is used in GO-2D.
Analysis and visualization
Data analysis is made flexible by subdividing the proce-
dure into sequential steps:
(1) Import data: GO-2D starts by reading the input files
containing reference and interesting gene lists (see Figure
1). It queries the genes by using Entrez Gene and Unigene
for human and organism specific IDs in GO for the other
three species (Drosophila melanogaster, Caenorhabditis ele-
gans, and Saccharomyces cerevisiae).
(2) Cross annotation: GO-2D refines a BP category by
sorting its genes into different CCs to form combined cat-
egories for finding cellular-localized modules enriched
with the interesting genes (see Figure 2). It also provides
the other 2-dimensional combinations of categories from
the three ontologies (BP, MF, and CC).
(3) Filter data: GO-2D provides options for finding gen-
eral or specific combined categories by determining their
sizes (the minimum/maximum numbers of included
genes) and/or depths in GO.
(4) Statistic test: GO-2D calculates the probability of a
combined category having the annotated number of inter-
esting genes by random chance, based on hypergeometric
or binomial statistical model [8], which is named "the
observed p value".
(5) Multiple tests correction: GO-2D offers Bonferroni
correction and FDR control [16] for multiple statistical
tests, the results are shown as "the corrected p  value".
When a total of n combined categories are tested, for the
Bonferroni correction, the corrected p value is pn, while p
is the observed p value. For the FDR control, let p (k)
denote the k-th smallest observed p value in a total of n
combined categories, then the FDR fk for hypothesis k is
bounded by np(k)/k ≤ fk. If an FDR of f is required for the
entire experiment, all hypotheses that satisfy p(k) ≤ fk/n
are declared as significant. The corrected p value for the k-
th smallest observed p value is np(k)/k. GO-2D can also
output all the observed p values, which can be used for
other complicated multiple tests correction by many other
existing tools such as the program for Storey's Q value
[17].
(6) Results: GO-2D allows users to save the results for
detailed examination of the identified modules. The tabu-
lar results collect the following information of a com-
bined category: GO IDs, names and depths of categories
(e.g. both BP and CC), numbers of genes and interesting
genes annotated in it, the observed p values, and the cor-
rected p values for multiple tests of the combined catego-
ries.
(7) Results visualization: GO-2D also provides tree view
to visualize the 2-dimensional modules (e.g. BP and CC).
GO-2D firstly displays the primary categories (e.g. BP,
user defined) in the primary tree, and then in the second-BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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A snapshot of GO-2D: the main user interface Figure 1
A snapshot of GO-2D: the main user interface.BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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ary tree, shows the sub-hierarchical structure of the sec-
ondary categories (e.g. CC) within each primary category
(see Figure 3). The user can select either BP or CC as the
"primary tree" for visualization. The selection has no
effect on the calculation of over-represented categories.
(8) Redundancy treatment: GO-2D suggests an empirical
way to reduce the redundancy among the resulting 2-
dimensional modules identified in the hierarchical struc-
ture of GO. When some modules share a same primary
category in the primary tree (e.g. BP), GO-2D focuses on
the combined category containing the most specific sec-
ondary category in the secondary tree (e.g. CC).
Details are described in the Additional file 1 (Figure 6, 7,
8, 9, 10, 11, 12, 13, 14, 15–Figure 16). Furthermore, GO-
A snapshot of GO-2D: the processing page Figure 2
A snapshot of GO-2D: the processing page.BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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2D provides additional standalone software GODAG for
visualizing the user selected GO category groups by
Directed Acyclic Graph (DAG). In the same DAG, it can
show several groups of GO categories marked with differ-
ent colours, which facilities visual comparisons for the
modules identified by different methods (See details in
A snapshot of GO-2D: the results page Figure 3
A snapshot of GO-2D: the results page.BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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Additional file 2, Figure 17, 18, 19, 20, 21, 22–Figure 23).
Also, GO-2D provides another additional standalone tool
ConfusionMatrix for comparing the resulting categories
identified by 1- and 2-dimensional approaches in GO-2D
(see details in Additional file 3, Figure 24, Figure 25).
Related software comparison
A recent study [18] has made a detailed comparison of 14
tools for ontological analysis of microarray data. Table 1
compares GO-2D to some typical ones. We highlight that
using combined categories for analysis is unique to GO-
2D.
Results
Based on the three GO ontologies (Biological_Process,
Cellular_Component and Molecular_Function) sepa-
rately, similar as other tools, GO-2D can also find 1-
dimensional modules enriched with interesting genes.
Because of the multiple tests problem, the observed p
value criterion is not justified for comparison, we thus use
Comparison between 1-dimensional and 2-dimensional modules in breast cancer Figure 4
Comparison between 1-dimensional and 2-dimensional modules in breast cancer. (A) Horizontal axis represents 
BP categories ranked by their depths in the BP ontology. Vertical axis represents CC categories ranked by their depths in the 
CC ontology. The thick blue lines represent the 1-dimensional modules and the red squares represent the 2-dimensional mod-
ules. (B) In the confusion matrix, we show the numbers of BP categories which are present in both 1-dimensional and 2-dimen-
sional modules; present in 1-dimensional but absent in 2-dimensional modules; absent in 1-dimensional but present in 2-
dimensional modules.BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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the same FDR criterion [16] to compare the powers of the
approaches to finding 1- and 2-dimensional modules.
Datasets
The breast cancer dataset contains 20849 genes measured
on 21 invasive lobular carcinoma (ILC) and 38 invasive
ductal carcinoma (IDC) samples [19]. The gastric cancer
dataset contains 20152 genes measured for 103 gastric
tumours and 29 normal gastric specimens [20]. Following
the pre-processing protocol proposed by Dudoit et al.
[21], we eliminate the genes with missing data in more
than 5% arrays, apply a base 2 logarithmic transformation
for the remaining expression values, and impute the miss-
ing values with zeros. Each experiment is normalized to
zero median across the genes. The breast and gastric can-
cer data finally comprise 8575 and 13037genes (Entrez
Gene) respectively, of which 318 and 3388 are differen-
tially expressed genes (DEGs) identified by t-test with FDR
1%, calculated by BRB ArrayTools [22].
Parameters
The parameters are set as following:
(1) Hypergeometric distribution
(2) FDR = 0.1
Comparison between 1-dimensional and 2-dimensional modules in gastric cancer Figure 5
Comparison between 1-dimensional and 2-dimensional modules in gastric cancer. (A) Horizontal axis represents 
BP categories ranked by their depths in the BP ontology. Vertical axis represents CC categories ranked by their depths in the 
CC ontology. The thick blue lines represent the 1-dimensional modules and the red squares represent the 2-dimensional mod-
ules. (B) In the confusion matrix, we show the numbers of BP categories which are present in both 1-dimensional and 2-dimen-
sional modules; present in 1-dimensional but absent in 2-dimensional modules; absent in 1-dimensional but present in 2-
dimensional modules.BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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A snapshot of GO-2D: depth selection Figure 6
A snapshot of GO-2D: depth selection.BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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(
3) MIN Gene Num 3; MAX Gene Num 150
(4) BP depth = Leaf Categories
(5) CC depth = 1 (for finding 1-dimensional modules
only based on BP), or CC depth>= 1 (for finding 2-dimen-
sional cellular-localized functional modules)
(6) Reduce redundancy
For breast cancer (318 interesting genes and 8575 refer-
ence genes), it takes about 9 min and 12 min for 1-dimen-
sional and 2-dimensional analysis respectively, with the
same computer (CPU: 2.8 GHz and Memory: 1 GB). For
gastric cancer (3388 interesting genes and 13037 reference
genes), it takes about 16 min and 22 for 1-dimensional
and 2-dimensional analysis, respectively.
Comparison of modules for breast cancer
With the statistical criterion FDR ≤ 0.1, we find eight cel-
lular-localized modules, and two 1-dimensional modules
A snapshot of GO-2D: depth filter Figure 7
A snapshot of GO-2D: depth filter.
A snapshot of GODAG: the main user interface Figure 17
A snapshot of GODAG: the main user interface.BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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based on BP only. As shown in Figure 4 and described in
Table 2 (the details of genes in each module are shown in
Additional file 4), we can find that, in addition to the bio-
logical processes appeared in the two 1-dimensional mod-
ules, the 2-dimensional approach discovers some new
specific processes relevant to disease. For example, the
A snapshot of GO-2D: primary tree view Figure 8
A snapshot of GO-2D: primary tree view.BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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A snapshot of GO-2D: secondary tree view Figure 9
A snapshot of GO-2D: secondary tree view.BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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A snapshot of GO-2D: gene information (Entrez gene) Figure 10
A snapshot of GO-2D: gene information (Entrez gene).BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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A snapshot of GO-2D: gene information (UniGene) Figure 11
A snapshot of GO-2D: gene information (UniGene).BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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A snapshot of GO-2D: unknown gene (Entrez gene) Figure 12
A snapshot of GO-2D: unknown gene (Entrez gene).BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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A snapshot of GO-2D: unknown gene (UniGene) Figure 13
A snapshot of GO-2D: unknown gene (UniGene).BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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A snapshot of GO-2D: FDR control Figure 14
A snapshot of GO-2D: FDR control.BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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A snapshot of GO-2D: corrected p value (bonferroni) Figure 15
A snapshot of GO-2D: corrected p value (bonferroni).BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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A snapshot of GO-2D: observed p value (no correction is selected) Figure 16
A snapshot of GO-2D: observed p value (no correction is selected).BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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biological process 'lipid biosynthesis' is discovered in the
cellular-localized module 'lipid biosynthesis & mitochon-
drion'. Using cellular location information, we find that
there are three DEGs among the 10 measured genes that
are annotated in this cellular-localized module, and the
observed p-value is 0.005 (FDR = 4.8%). However, when
we do not use cellular location information, we find four
DEGs among the 108 measured genes that are annotated
in 'lipid biosynthesis', and the observed p-value is only
0.57 (FDR = 65.6%). This example clearly demonstrates
that finding cellular-localized modules is a useful
approach to detecting additional disease relevant mod-
ules.
A cellular-localized module identified is "BP: oxygen and
reactive oxygen species metabolism" in "CC: extracellular
region part". Oxidative stress (generating reactive oxygen
species) has been linked to cancer initiation and progres-
sion. It has been suggested [23] that G. lucidum inhibits
the oxidative stress-induced invasive behavior of breast
cancer cells by modulating extracellular signal-regulated
protein kinases signalling.
For the cellular-localized module "BP: lipid biosynthesis"
in "CC: mitochondrial", Zhao, et al. [19] suggested that
lipid/fatty acid metabolism may be partially responsible
for different proliferation rates of tumor cells in ILCs and
IDCs. In addition, mtDNA polymorphisms may be under-
appreciated factors in breast carcinogenesis [24].
The third example is "BP: G-protein coupled receptor pro-
tein signalling pathway" in "CC: integral to plasma mem-
brane", Holland JD et al [25] showed that CXCR4 is
subject to controlled regulation in breast cancer cells via
differential G protein-receptor complex formation, and
this regulation may play a role in the transition from non-
metastatic to malignant tumors.
The last example is for the "BP: complement activation" in
"CC: extracellular region". Caragine TA et al. provided
direct in vivo evidence that an inhibitor of complement
activation can facilitate breast tumor growth by modulat-
ing C3 deposition [26].
Comparison of modules for gastric cancer
With the statistical criterion FDR ≤ 0.1, we find four 1-
dimensional modules when based on BP only, and thir-
teen cellular-localized modules. In addition, as shown in
Figure 5 and described in Table 3 (the details of genes in
each module are shown in Additional file 4), the 2-dimen-
sional approach detects new disease relevant biological
processes combined with the cellular-localization infor-
mation.
For example, for the cellular-localized functional module
"BP: negative regulation of cell proliferation" in "CC:
cytoplasm", Li X et al. [27] suggested that TGF-beta1
affects both proliferation and apoptosis of gastric cancer
A snapshot of GODAG: input page Figure 18
A snapshot of GODAG: input page.BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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cells through the regulation of p15 and p21, and induces
transient expression of Smad 7 as a negative feedback
modulation of TGF-beta1 signal.
Another example is the module "BP: cell cycle arrest" in
"CC: cytoplasm". Zheng JY et al. showed that p27 (KIP1)
can lead to apoptosis in gastric carcinoma cells [28].
Furthermore, for the same BP, the cellular-localized func-
tional modules are described by additional localization
information. For example, for the two cellular-localized
modules, "BP: rRNA processing" in "CC: protein com-
plex" and "BP: rRNA processing" in "CC: nucleolus", it
has been shown [29] that by reducing the occupancy of
the SL1 complex subunits on the rRNA gene promoter and
inducing dissociation of the SL1 complex subunits, the
transcription of rRNAs is controlled by tumor suppressor
PTEN. In addition, a strong correlation has been observed
between Nucleolar Organizer regions (loops of DNA
encoding ribosomal RNA) counts and metastasis as well
as the microscopic type of the gastric carcinoma [30].
Discussion
When selecting modules from thousands of categories
hierarchically structured in GO, the main difficulty is to
set statistical significance threshold accounting for the
multiplicity of testing. For multiple tests problem, GO-2D
adopts the standard methods of Bonferroni correction
and FDR control [16,31], which are usually conservative
for the non-independent categories organized in ontolo-
gies. It has been suggested that re-sampling simulations
might be the most reliable way for selecting the significant
modules from thousands of categories organized in GO
[32]. However, numerical simulations usually suffer from
heavy computation burden, and more efficient and feasi-
ble re-sampling algorithms deserve further studies [32].
GO-2D outputs the observed p values for the combined
categories, which can be used as input data for some more
complicated multiple comparisons by existing tools, e.g.,
the program for Storey's Q value [17].
Since a BP category usually encompasses the genes
involved in distinct processes occurring in different cellu-
A snapshot of GODAG: result page Figure 19
A snapshot of GODAG: result page.BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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lar compartments [12] and the genes even within a same
process may show a clear expression distinction with
respect to their cellular localizations [13], the current 1-
dimensional approaches are not sufficient enough for
identifying the diseases relevant modules. The 2-dimen-
sional approach finds which parts of a BP category, occur-
ring in some cellular compartments, are significantly
relevant to disease. As demonstrated by its applications to
two cancers in this study, the cellular-localized modules
reveal some new biological processes relevant to the dis-
eases in both datasets, in addition to the BPs identified in
the 1-dimensional modules. We note that, conceptually,
the 2-dimensional approach should cover all BPs identifi-
able by the 1-dimensional approach, but it might not be
always so because of the approximation procedure in the
multiple test corrections. Therefore, GO-2D provides both
1- and 2-dimensional approaches for identifying interest-
ing modules of possible disease relevance. When CC
Depth is chosen equal to one, the GO-2D just finds only
1-dimensional modules as other software do. Addition-
A snapshot of GODAG: search page Figure 21
A snapshot of GODAG: search page.
A snapshot of GODAG: edit page Figure 20
A snapshot of GODAG: edit page.BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
Page 22 of 27
(page number not for citation purposes)
A snapshot of GODAG: save page Figure 23
A snapshot of GODAG: save page.
A snapshot of GODAG: the DAG of resulting categories Figure 22
A snapshot of GODAG: the DAG of resulting categories.BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
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ally, GO-2D provides the numbers of genes (from the
gene expression dataset) annotated in the original BP and
CC categories of each 2-dimensional module, so the user
can filter the results (e.g., according to the overlapping of
the original BP and CC categories) to choose their interest-
ing subsets. We conclude that GO-2D is a useful tool of
detecting disease relevant modules for one of the most
important routine task of the functional analysis and bio-
logical interpretation of the high-throughput microarray
data.
In a recent study, we have also shown the power of the 2-
dimensional cellular-localized modules for dissecting the
heterogeneity of the complex cancers, i.e. discovering dis-
ease subtypes by unsupervised clustering analysis [7].
However, there are still open spaces for further improving
the module-based analysis approaches. For example,
because changes in gene expression patterns can have var-
ious forms, different statistical measures (and their thresh-
olds) for finding DEGs and thus the corresponding
functional modules should be further explored. Further-
more, we will integrate GO-2D with more data resources
in a future version.
Conclusion
In summary, we have developed a novel tool for identify-
ing the well-characterized 2-dimensional modules, e.g., in
terms of both biological processes and cellular locations.
The numerical analyses demonstrate that the 2-dimen-
sional functional modules identified in two cancer data-
sets enjoy explicit relevance to cancer biology, thus
suggesting hints for further experiments confirming the
novel modular mechanisms.
Availability and requirements
Project Name: GO-2D
Project home page:
For Windows version: http://www.systembiology.cn/go-
2d/
For both Windows and Linux version: http://
www.hrbmu.edu.cn/go-2d/index.htm
Operating system(s): Windows 2000 (XP) or Linux
Programming language: Java
Other requirements: Java 1.5
License: GNU General Public License
Restrictions to use by non-academics: Contact corre-
sponding author
Abbreviations
Gene Ontology (GO), biological process (BP), molecular
function (MF), cellular component (CC), differentially
expressed genes (DEGs).
A snapshot of ConfusionMatrix: input page Figure 24
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A snapshot of ConfusionMatrix: results page Figure 25
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Table 1: Comparison of GO-2D with related software
Onto-Express FatiGO GoMiner GOstat GO-2D
Analysis scope 3 single categories 3 single categories 3 single categories 3 single categories Combined categories
Correction for multiple tests Šidák, Holm, Bonferroni, FDR Step-down minP, FDR [16, 31] Relative enrichment Holm, FDR [16] Bonferroni, FDR [16]
Statistical Analysis Hypergeometric, Binomial,χ2, 
Fisher's exact test,
Fisher's exact test Fisher's exact test χ2, Fisher's exact test, Hypergeometric, Binomial
Visualization Flata, Tree Flata, Tree Tree, DAG Flata Tree, DAG
Application Web Web Stand-alone Web Stand-alone
Flata: The results are shown without hierarchical structure
Table 2: Functional modules for breast cancer (FDR ≤ 0.1)
Dimension Biological Process Name 
(# of genes d in BP)
Cellular Component Name (# of genes d in CC) # of genes d in 2D module Observed P Value
1Db nucleosome assembly (31) 8.33E-04
learning and/or memory (7) --- --- 1.58E-03
2Dc nucleosome assembly (31) nucleosome (21) 20 6.19E-05
nucleosome assembly (31) nucleus (1779) 31 8.33E-04
learning and/or memory (7) cell part (4794) 5 4.78E-04
oxygen and reactive oxygen species metabolism (36) extracellular region part (257) 5 4.78E-04
lipid biosynthesis (108) mitochondrion (376) 10 4.99E-03
complement activation (14) extracellular region (388) 11 6.68E-03
transmembrane receptor protein tyrosine kinase 
signalling pathway (73)
cytoplasmic part (1297) 11 6.68E-03
G-protein coupled receptor protein signalling pathway 
(172)
integral to plasma membrane (459) 61 7.07E-03
1Db: Functional modules based on biological process (one-dimensional modules).
2Dc: Cellular-localized functional modules (two-dimensional modules).
# of genes d: the numbers of genes from the gene expression dataset (annotated in the original BP/CC categories or 2-dimensional modules)
Table 3: Functional modules for gastric cancer (FDR ≤ 0.1)
Dimension Biological Process Name 
(# of genes d in BP)
Cellular Component Name 
(# of genes d in CC)
# of genes d in 2D module Observed P Value
1Db rRNA processing (46) 1.07E-05
regulation of cyclin dependent protein kinase activity (28) --- --- 2.26E-05
Digestion (26) 6.04E-04
traversing start control point of mitotic cell cycle (5) 1.18E-03
2Dc rRNA processing (46) protein complex (1135) 22 2.22E-04
rRNA processing (46) nucleolus (73) 20 1.34E-03
regulation of cyclin dependent protein kinase activity (28) nucleus (2425) 18 5.27E-05
Digestion (26) cell (6889) 16 4.09E-04
traversing start control point of mitotic cell cycle (5) nucleus (2425) 5 1.18E-03
electron transport (229) endoplasmic reticulum (378) 49 1.53E-04
electron transport (229) membrane (2978) 102 2.66E-04
electron transport (229) microsome (76) 29 7.80E-04
cell cycle arrest (50) cytoplasm (2362) 14 4.77E-04
negative regulation of cell proliferation (107) cytoplasm (2362) 37 8.41E-04
NLS-bearing substrate import into nucleus (12) nuclear part (465) 5 1.18E-03
one-carbon compound metabolism (24) intracellular membrane-bound organelle (3675) 7 1.67E-03
Note: See the footnotes of Table 2.BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
Page 26 of 27
(page number not for citation purposes)
Authors' contributions
ZG and JZ described and specified the features of, and
problems to be solved by GO-2D; JW implemented cod-
ing of the software; MZ, DY, YL, DW and GX participated
in testing the program and applied the data mining strat-
egy to the field datasets; all authors participated in read-
ing, approving and revising the manuscript.
Additional material
Acknowledgements
This work was supported in part by the National Natural Science Founda-
tion of China (Grant Nos. 30170515, 30370388), the National High Tech 
Development Project of China (Grant Nos. 2003AA2Z2051 and 
2002AA2Z2052).
References
1. Rives AW, Galitski T: Modular organization of cellular net-
works.  Proc Natl Acad Sci USA 2003, 100(3):1128-1133.
2. Hartwell LH, Hopfield JJ, Leibler S, Murray AW: From molecular
to modular cell biology.  Nature 1999, 402(6761 Suppl):C47-52.
3. Segal E, Friedman N, Koller D, Regev A: A module map showing
conditional activity of expression modules in cancer.  Nat
Genet 2004, 36(10):1090-1098.
4. Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, Kittrell
FS, Zahnow CA, Patterson N, Golub TR, Ewen ME: A mechanism
of cyclin D1 action encoded in the patterns of gene expres-
sion in human cancer.  Cell 2003, 114(3):323-334.
5. Guo Z, Zhang T, Li X, Wang Q, Xu J, Yu H, Zhu J, Wang H, Wang C,
Topol EJ, et al.: Towards precise classification of cancers based
on robust gene functional expression profiles.  BMC Bioinfor-
matics 2005, 6(1):58.
6. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar
J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, et al.: PGC-
1alpha-responsive genes involved in oxidative phosphoryla-
tion are coordinately downregulated in human diabetes.  Nat
Genet 2003, 34(3):267-273.
7. Xu JZ, Guo Z, Zhang M, Li X, Li YJ, Rao SQ: Peeling off the hidden
genetic heterogeneities of cancers based on disease-relevant
functional modules.  Mol Med 2006, 12(1–3):25-33.
8. Khatri P, Bhavsar P, Bawa G, Draghici S: Onto-Tools: an ensemble
of web-accessible, ontology-based tools for the functional
design and interpretation of high-throughput gene expres-
sion experiments.  Nucleic Acids Res 2004:W449-456.
9. Al-Shahrour F, Diaz-Uriarte R, Dopazo J: FatiGO: a web tool for
finding significant associations of Gene Ontology terms with
groups of genes.  Bioinformatics 2004, 20(4):578-580.
10. Zeeberg BR, Feng W, Wang G, Wang MD, Fojo AT, Sunshine M, Nar-
asimhan S, Kane DW, Reinhold WC, Lababidi S, et al.: GoMiner: a
resource for biological interpretation of genomic and pro-
teomic data.  Genome Biol 2003, 4(4):R28.
11. Beissbarth T, Speed TP: GOstat: find statistically overrepre-
sented Gene Ontologies within a group of genes.  Bioinformatics
2004, 20(9):1464-1465.
12. Zhou X, Kao MC, Wong WH: Transitive functional annotation
by shortest-path analysis of gene expression data.  Proc Natl
Acad Sci USA 2002, 99(20):12783-12788.
13. Jimenez JL, Mitchell MP, Sgouros JG: Microarray analysis of
orthologous genes: conservation of the translational machin-
ery across species at the sequence and expression level.
Genome Biol 2003, 4(1):R4.
14. NCBI Web Page   [ftp://ftp.ncbi.nlm.nih.gov/gene/DATA/]
15. GO Consortium   [http://www.geneontology.org/]
16. Benjamini Y, Y H: Controlling the false discovery rate: a practi-
cal and powerful approach to multiple testing.  Journal of the
Royal Statistical Society Series B (Methodological) 1995, 57(1):289-300.
17. Storey's Q Value   [http://faculty.washington.edu/jstorey/qvalue]
18. Khatri P, Draghici S: Ontological analysis of gene expression
data: current tools, limitations, and open problems.  Bioinfor-
matics 2005, 21(18):3587-3595.
19. Zhao H, Langerod A, Ji Y, Nowels KW, Nesland JM, Tibshirani R,
Bukholm IK, Karesen R, Botstein D, Borresen-Dale AL, et al.: Differ-
ent gene expression patterns in invasive lobular and ductal
carcinomas of the breast.  Mol Biol Cell 2004, 15(6):2523-2536.
20. Chen X, Leung SY, Yuen ST, Chu KM, Ji J, Li R, Chan AS, Law S, Troy-
anskaya OG, Wong J, et al.: Variation in gene expression pat-
terns in human gastric cancers.  Mol Biol Cell 2003,
14(8):3208-3215.
21. Dudoit S, Fridlyand J, Speed TP: Comparison of discrimination
methods for the classification of tumors using gene expres-
sion data.  Journal of the American Statistical Association 2002,
97(457):77-87.
22. BRB ArrayTools   [http://linus.nci.nih.gov/BRB-ArrayTools.html]
23. Thyagarajan A, Jiang J, Hopf A, Adamec J, Sliva D: Inhibition of oxi-
dative stress-induced invasiveness of cancer cells by Gano-
derma lucidum is mediated through the suppression of
interleukin-8 secretion.  Int J Mol Med 2006, 18(4):657-664.
24. Canter JA, Kallianpur AR, Parl FF, Millikan RC: Mitochondrial DNA
G10398A polymorphism and invasive breast cancer in Afri-
can-American women.  Cancer Res 2005, 65(7):8028-8033.
25. Holland JD, Kochetkova M, Akekawatchai C, Dottore M, Lopez A,
McColl SR: Differential functional activation of chemokine
receptor CXCR4 is mediated by G proteins in breast cancer
cells.  Cancer Res 2006, 66(8):4117-4124.
26. Caragine TA, Okada N, Frey AB, Tomlinson S: A tumor-expressed
inhibitor of the early but not late complement lytic pathway
enhances tumor growth in a rat model of human breast can-
cer.  Cancer Res 2002, 62(4):1110-1115.
27. Li X, Zhang YY, Wang Q, Fu SB: Association between endog-
enous gene expression and growth regulation induced by
TGF-beta1 in human gastric cancer cells.  World J Gastroenterol
2005, 11(1):61-68.
Additional File 1
Manual of GO-2D. containing the manual of GO-2D, which is a stand-
alone tool that identifies 2-dimensional functional modules enriched with 
interesting genes.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-30-S1.pdf]
Additional File 2
Manual of GODAG. containing the manual of GODAG, which is a 
stand-alone tool that allows the users to visualize their interesting GO cat-
egories as a directed acyclic graph.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-30-S2.pdf]
Additional File 3
Manual of ConfusionMatrix. containing the manual of ConfusionMa-
trix, which is a tool for comparing the resulting categories identified by 1- 
and 2-dimensional approaches in GO-2D.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-30-S3.pdf]
Additional File 4
Gene information. spreadsheet containing the names of all the genes in 
the modules shown in Table 2 and Table 3.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-30-S4.xls]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Genomics 2007, 8:30 http://www.biomedcentral.com/1471-2164/8/30
Page 27 of 27
(page number not for citation purposes)
28. Zheng JY, Wang WZ, Li KZ, Guan WX, Yan W: Effect of
p27(KIP1) on cell cycle and apoptosis in gastric cancer cells.
World J Gastroenterol 2005, 11(45):7072-7077.
29. Zhang C, Comai L, Johnson DL: PTEN represses RNA Polymer-
ase I transcription by disrupting the SL1 complex.  Mol Cell Biol
2005, 25(16):6899-6911.
30. Prakash I, Mathur RP, Kar P, Ranga S, Talib VH: Comparative eval-
uation of cell proliferative indices and epidermal growth fac-
tor receptor expression in gastric carcinoma.  Indian J Pathol
Microbiol 1997, 40(4):481-490.
31. Benjamini Y, Drai D, Elmer G, Kafkafi N, I G: Controlling the false
discovery rate in behavior genetics research.  Behav Brain Res
2001, 125(1–2):279-284.
32. Osier MV, Zhao H, Cheung KH: Handling multiple testing while
interpreting microarrays with the Gene Ontology Database.
BMC Bioinformatics 2004, 5(1):124.